157 related articles for article (PubMed ID: 8754091)
1. [The use of Debridat in treating the irritable bowel syndrome].
Parfenov AI
Voen Med Zh; 1996 May; 317(5):37-8. PubMed ID: 8754091
[No Abstract] [Full Text] [Related]
2. Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome.
Kountouras J; Chatzopoulos D; Zavos C; Boura P; Venizelos J; Kalis A
Hepatogastroenterology; 2002; 49(43):193-7. PubMed ID: 11941952
[TBL] [Abstract][Full Text] [Related]
3. A three-part controlled study of trimebutine in the treatment of irritable colon syndrome.
Lüttecke K
Curr Med Res Opin; 1980; 6(6):437-43. PubMed ID: 6988171
[TBL] [Abstract][Full Text] [Related]
4. Double blind trial of trimebutine in the irritable bowel syndrome.
Fielding JF
Ir Med J; 1980 Oct; 73(10):377-9. PubMed ID: 7000730
[No Abstract] [Full Text] [Related]
5. [A randomized and case-control clinical study on trimebutine maleate in treating functional dyspepsia coexisting with diarrhea-dominant irritable bowel syndrome].
Zhong YQ; Zhu J; Guo JN; Yan R; Li HJ; Lin YH; Zeng ZY
Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):899-902. PubMed ID: 18261269
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of action of trimebutine maleate on gastro-colic reflex in patients with irritable bowel syndrome].
Matsue T; Yamato S; Umeda N
Nihon Heikatsukin Gakkai Zasshi; 1990 Apr; 26(2):89-92. PubMed ID: 2273694
[No Abstract] [Full Text] [Related]
7. The effect of trimebutine on the psychosocial adjustment to illness in the irritable bowel syndrome.
Dumitraşcu DL; Stănculete M
Rom J Intern Med; 2006; 44(3):273-80. PubMed ID: 18386606
[TBL] [Abstract][Full Text] [Related]
8. Contemporary thoughts on the treatment of irritable bowel syndrome.
Giaquinta D
Manag Care Interface; 2002 Aug; 15(8):19-20, 22. PubMed ID: 12229060
[No Abstract] [Full Text] [Related]
9. [Clinical and instrumental evaluation by multiple colonic manometry of tiropramide, trimebutine and octylonium bromide in the irritable colon: I. Administration by single i.v].
Galeone M; Stock F; Moise G; Cacioli D; Benazzi E; Riva A
Pharmatherapeutica; 1986; 4(7):445-56. PubMed ID: 3960945
[TBL] [Abstract][Full Text] [Related]
10. [Meteospazmil and its place in treating patients with irritable bowel syndrome].
Minushkin ON
Eksp Klin Gastroenterol; 2002; (1):94-7. PubMed ID: 12271597
[No Abstract] [Full Text] [Related]
11. Trimebutine: mechanism of action, effects on gastrointestinal function and clinical results.
Delvaux M; Wingate D
J Int Med Res; 1997; 25(5):225-46. PubMed ID: 9364286
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and instrumental evaluation by multiple colonic manometry of tiropramide, trimebutine and octylonium bromide in irritable colon. II. Repeated oral administration].
Galeone M; Benazzi E; Bossi M; Moise G; Riva A; Stock F
Pharmatherapeutica; 1986; 4(8):496-509. PubMed ID: 3714757
[TBL] [Abstract][Full Text] [Related]
13. Lotronex(tm): therapy for diarrhea predominant irritable bowel syndrome.
McGahan L
Issues Emerg Health Technol; 2000 Oct; (11):1-5. PubMed ID: 11902219
[No Abstract] [Full Text] [Related]
14. [Comparative clinical study of the combination of clidinium(br)-chlordiazepoxide and trimebutine in the treatment of functional colopathies].
Copé R
Med Chir Dig; 1981; 10(8):713-7. PubMed ID: 6896078
[No Abstract] [Full Text] [Related]
15. A case of trimebutine-induced anaphylaxis.
Lee SY; Kim MY; Kang SY; Song WJ; Kang HR
Allergol Int; 2011 Dec; 60(4):555-6. PubMed ID: 22113162
[TBL] [Abstract][Full Text] [Related]
16. [New drug for irritable bowel syndrome].
Hennemann A
Med Monatsschr Pharm; 2001 Apr; 24(4):106-8. PubMed ID: 11338633
[No Abstract] [Full Text] [Related]
17. Update on irritable bowel syndrome.
Bergmann KA
Postgrad Med J; 2003 Dec; 79(938):715. PubMed ID: 14707260
[No Abstract] [Full Text] [Related]
18. FDA OK's two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tricky.
Horwitz BJ
Health News; 2002 Oct; 8(10):1-2. PubMed ID: 12416480
[No Abstract] [Full Text] [Related]
19. Glaxo Wellcome withdraws irritable bowel syndrome medication.
FDA Consum; 2001; 35(1):3. PubMed ID: 11930921
[No Abstract] [Full Text] [Related]
20. Allergic contact dermatitis due to trimebutine.
Reyes JJ; Fariña MC
Contact Dermatitis; 2001 Sep; 45(3):164. PubMed ID: 11553143
[No Abstract] [Full Text] [Related]
[Next] [New Search]
